These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30926354)

  • 1. Anti-vimentin antibodies in transplant and disease.
    Divanyan T; Acosta E; Patel D; Constantino D; Lopez-Soler RI
    Hum Immunol; 2019 Aug; 80(8):602-607. PubMed ID: 30926354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and early outcomes associated with pre-transplant antivimentin antibodies in the cardiac transplantation population.
    Young RK; Dale B; Russell SD; Zachary AA; Tedford RJ
    Clin Transplant; 2015 Aug; 29(8):685-8. PubMed ID: 25982351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation.
    Jurcevic S; Ainsworth ME; Pomerance A; Smith JD; Robinson DR; Dunn MJ; Yacoub MH; Rose ML
    Transplantation; 2001 Apr; 71(7):886-92. PubMed ID: 11349721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C4d deposition is correlated with the level of antivimentin antibody in rat kidneys undergoing chronic allograft nephropathy.
    Yang L; Lu YP; Luo GH; Song J; Tu ZD; Li YP
    Transplant Proc; 2008 Oct; 40(8):2786-9. PubMed ID: 18929862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-cell surface endothelial antibodies in sera from cardiac and kidney transplant recipients: association with chronic rejection.
    Ferry BL; Welsh KI; Dunn MJ; Law D; Proctor J; Chapel H; Yacoub MH; Rose ML
    Transpl Immunol; 1997 Mar; 5(1):17-24. PubMed ID: 9106330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Antibody-Mediated Kidney Transplant Rejection Associated With Anti-Vimentin Antibodies: A Case Report.
    Rampersad C; Shaw J; Gibson IW; Wiebe C; Rush DN; Nickerson PW; Ho J
    Am J Kidney Dis; 2020 Jan; 75(1):138-143. PubMed ID: 31515140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vimentin antibodies: a non-HLA antibody as a potential risk factor in renal transplantation.
    Carter V; Shenton BK; Jaques B; Turner D; Talbot D; Gupta A; Chapman CE; Matthews CJ; Cavanagh G
    Transplant Proc; 2005 Mar; 37(2):654-7. PubMed ID: 15848491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-vimentin Antibodies Present at the Time of Transplantation May Predict Early Development of Interstitial Fibrosis/Tubular Atrophy.
    Lopez-Soler RI; Borgia JA; Kanangat S; Fhied CL; Conti DJ; Constantino D; Ata A; Chan R; Wang Z
    Transplant Proc; 2016; 48(6):2023-33. PubMed ID: 27569939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of antibodies in transplant-associated cardiac allograft vasculopathy.
    Rose ML
    Z Kardiol; 2000; 89 Suppl 9():IX/11-5. PubMed ID: 11151778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The autoimmune response to vimentin after renal transplantation in nonhuman primates is immunosuppression dependent.
    Jonker M; Danskine A; Haanstra K; Wubben J; Kondova I; Kuhn EM; Rose M
    Transplantation; 2005 Aug; 80(3):385-93. PubMed ID: 16082335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive association of anticytoskeletal endothelial cell antibodies and cardiac allograft rejection.
    Alvarez-Márquez A; Aguilera I; Blanco RM; Pascual D; Encarnación-Carrizosa M; Alvarez-López MR; Wichmann I; Núñez-Roldán A
    Hum Immunol; 2008 Mar; 69(3):143-8. PubMed ID: 18396205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of children undergoing cardiac transplantation with high Panel Reactive Antibodies.
    Asante-Korang A; Jacobs JP; Ringewald J; Carapellucci J; Rosenberg K; McKenna D; McCormack J; Wilmot I; Gjeldum A; Lopez-Cepero M; Sleasman J
    Cardiol Young; 2011 Dec; 21 Suppl 2():124-32. PubMed ID: 22152539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of non-HLA antibodies directed against angiotensin II type 1 receptor (AT1R) on early renal transplant outcomes.
    Banasik M; Boratyńska M; Kościelska-Kasprzak K; Kamińska D; Bartoszek D; Zabińska M; Myszka M; Zmonarski S; Protasiewicz M; Nowakowska B; Hałoń A; Chudoba P; Klinger M
    Transpl Int; 2014 Oct; 27(10):1029-38. PubMed ID: 24909812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies to vimentin cause accelerated rejection of cardiac allografts.
    Mahesh B; Leong HS; McCormack A; Sarathchandra P; Holder A; Rose ML
    Am J Pathol; 2007 Apr; 170(4):1415-27. PubMed ID: 17392180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin isotype switching of antibodies to vimentin is associated with development of transplant glomerulopathy following human renal transplantation.
    Gunasekaran M; Maw TT; Santos RD; Shenoy S; Wellen J; Mohanakumar T
    Transpl Immunol; 2017 Dec; 45():42-47. PubMed ID: 28911876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of damaged tubular epithelium in renal allografts by determination of vimentin expression.
    Muramatsu M; Miyagi M; Ishikawa Y; Aikawa A; Mizuiri S; Ohara T; Ishii T; Hasegawa A
    Int J Urol; 2004 Nov; 11(11):954-62. PubMed ID: 15509197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of anti-vimentin antibodies in allograft rejection.
    Rose ML
    Hum Immunol; 2013 Nov; 74(11):1459-62. PubMed ID: 23777935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies against nucleolin in recipients of organ transplants.
    Qin Z; Lavingia B; Zou Y; Stastny P
    Transplantation; 2011 Oct; 92(7):829-35. PubMed ID: 21869741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early post-transplant immune monitoring can predict long-term kidney graft survival: soluble CD30 levels, anti-HLA antibodies and IgA-anti-Fab autoantibodies.
    Amirzargar MA; Amirzargar A; Basiri A; Hajilooi M; Roshanaei G; Rajabi G; Mohammadiazar S; Solgi G
    Hum Immunol; 2014 Jan; 75(1):47-58. PubMed ID: 24055694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Emerging Importance of Non-HLA Autoantibodies in Kidney Transplant Complications.
    Cardinal H; Dieudé M; Hébert MJ
    J Am Soc Nephrol; 2017 Feb; 28(2):400-406. PubMed ID: 27798244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.